Atlas Trials

Phase 2 Study of MM-093 to Treat Patients With Uveitis

Clinical trial NCT00444743 · COMPLETED

Trial details

NCT number
NCT00444743
Sponsor
Merrimack Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Uveitis
Start date
2007-02-01
Primary completion
2008-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.